Heidelberg Pharma AG (ETR:HPHA)

Revenue by Product

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Antibody Drug Conjugates	9.86M
Antibody Drug Conjugates Growth	-46.75%

Revenue by Geography

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
China	4.74M
China Growth	-42.22%
United States	4.67M
United States Growth	-47.98%
Rest of the World	242.00K
Rest of the World Growth	-66.71%
Switzerland	145.00K
Switzerland Growth	178.85%
Germany	60.00K
Germany Growth	-89.07%